English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 21 June 2018, 10:50 HKT/SGT
Share:
    

Source: Kintaro Cells Power
Kintaro Cells Power establishes new partnership with Tokyo Medical University to advance stem cell research
Ground-breaking stem cell research examining the differences between young and old stem cells can contribute to better stem cell treatment for all.

SINGAPORE, June 21, 2018 - (Media OutReach) - In partnership with Tokyo Medical University, Kintaro Cells Power is working to build the research around mesenchymal stem cells and improve the quality of life for all. The two have embarked on a joint research project to examine the differences in the effect that old and young stem cells have on the body, in a bid to improve future stem cell treatments for patients.

The difference between old and young stem cells
Over time, young stem cells wear down through the process of ageing, being exposed to the effects of DNA damage, oxidative stress, mitochondrial damage, and inflammation. The onset of ageing increases the risk of diseases, hormonal changes and differences in energy and metabolism. However, the effects of ageing can be reversed if the patient receives stem cells from young and healthy donors. The researchers have also found that the effect of stem cells on patients is stronger if they receive allogenic rather than autologous cells. In other words, the patient is more likely to see better results if they receive donor cells rather than have their own cells re-introduced into their bodies.

Expansion plans
With the goal to bring stem cell treatment to as many patients as possible, Kintaro Cells Power is expanding their reach with plans to open new production facilities in Malaysia, Vietnam, Indonesia and Thailand. These production facilities have the goal of improving the efficiency of stem cell cultivation, reducing the cost of production while ensuring that only the highest standards are met for stem cell production. In these countries, Kintaro Cells Power will also conduct clinical trials to ensure the viability of their stem cells for all regions they operate in.

"We want to bring the healing power of Kintaro Cells(TM) to more people and help them experience a better quality of life. Having performed over 1200 stem cell treatments since 2011, we want to continue providing safe and high-quality stem cell treatment to more patients around the world", said Alexei Gladkov, CEO, Kintaro Cells Power.

Using only the highest quality of stem cells
To provide the best treatment for patients, Kintaro Cells(TM) are checked by medical professionals at Tokyo Medical University to ensure that only the highest quality of mesenchymal stem cells is used. Kintaro Cells Power has also amassed more than 50 certificates and patents, gaining credibility with medical institutions worldwide.

The benefits of Kintaro Cells(TM)
Kintaro Cells(TM) are able to improve your quality of life by contributing to your overall health, therefore making you feel younger, healthier and more revitalised. These are mesenchymal stem cells obtained from the bone marrow and extracted from vetted young and healthy donors between the ages of 18 to 24 years. The live cells are cultivated in laboratories and injected fresh into recipients within 48 hours of harvesting. A Kintaro Cells(TM) infusion puts 200 million stem cells into the patient's body, returning stem cell levels to that of a 30-year-old. Kintaro Cells(TM) are able to improve one's overall health, preventing the onset of heart disease, kidney disease, and even diabetes. It also has rejuvenating properties, helping to slow down the ageing process of those who receive Kintaro Cells(TM), giving them a new lease of life.
For more information about Kintaro Cells Power, visit http://kintarocellspower.co.jp/.

About Kintaro Cells Power
Kintaro Cells Power was founded in 2011 and aims to use the power of mesenchymal stem cells to rejuvenate, increase life expectancy and improve the quality of life for all. Based on more than 50 years of Russian technology, Kintaro Cells Power brings the highest quality of stem cell treatment to end-users, possessing the ability to revitalize your body and increase your overall well-being from the inside. Kintaro Cells are recommended for men and women who want to experience rejuvenation, prolong the active period of their life and benefit from a better overall quality of life throughout their golden years.

For more information about Kintaro Cells Power, visit http://kintarocellspower.co.jp/. For up to date information about upcoming seminars, follow Kintaro Cells Power on Facebook at: https://www.facebook.com/CellsPowerJapan/

For media enquiries, please contact Right Hook Communications:
Nurhayati Ghani, Account Executive
E: nurhayati@righthook.com.sg
Tel: +65 8218 4422

Sarah Ho, Public Relations Executive
E: sarah@righthook.com.sg
Tel: +65 9711 5798

Topic: Press release summary
Source: Kintaro Cells Power


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Aemetis to Review First Quarter 2024 Financial Results on May 9, 2024  
May 4, 2024 01:00 HKT/SGT
Peapack Private Hires Jerry Dominguez as Senior Managing Director  
May 4, 2024 01:00 HKT/SGT
UVify Sets New Guinness World Record With 5,293 IFO Drones in Spectacular Aerial Display  
May 4, 2024 00:00 HKT/SGT
2024 CAP Consumer Survey Shows Increase in Piracy on Social Media and Messaging Platforms in Asia Pacific  
May 3, 2024 20:40 HKT/SGT
SDAI Limited: Positive Outcomes Since New Board took over in June 2023  
May 3, 2024 20:00 HKT/SGT
Loop Industries and Ester Industries Ltd. Announce Joint Venture Agreement to Build an Infinite Loop(TM) Manufacturing Facility in India  
May 3, 2024 20:00 HKT/SGT
Singapore's top general insurer debuts trading on Asia's leading digital exchange, AltaX   
May 3, 2024 10:30 HKT/SGT
Nephros Schedules First Quarter 2024 Financial Results Conference Call  
May 3, 2024 08:31 HKT/SGT
Nass Valley Gateway Ltd Announces It Will File Its 2023 EOY Audited Financials by June 28th, 2024, Within the Extension Granted by the BCSC  
May 3, 2024 08:26 HKT/SGT
UPDATE: Kaplan Fox Files Class Action to Recover Losses for Investors Who Were Short The Barclays Bank PLC iPath Series B S&P 500 VIX Short-Term Futures ETN (CBOE: VXX) ("VXX")  
May 3, 2024 08:05 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575